Chemomab Therapeutics (CMMB) Net Income towards Common Stockholders (QoQ) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Chemomab Therapeutics | 959.23 Mn | 948.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,025.20% |
| Dec 31, 2024 | -815.68% |
| Sep 30, 2024 | -4.08% |
| Jun 30, 2024 | -6.13% |
| Mar 31, 2024 | 13.20% |
| Dec 31, 2023 | -18.47% |
| Sep 30, 2023 | -46.96% |
| Jun 30, 2023 | -9.29% |
| Mar 31, 2023 | 5.56% |
| Dec 31, 2022 | 2.13% |
| Sep 30, 2022 | 11.02% |
| Jun 30, 2022 | 242.59% |
| Mar 31, 2022 | -1.35% |
| Dec 31, 2021 | -69.68% |
| Sep 30, 2021 | -7.15% |
| Dec 31, 2019 | -154.84% |
| Sep 30, 2019 | 904.43% |
| Jun 30, 2019 | -90.87% |
| Mar 31, 2019 | 914.80% |
| Dec 31, 2018 | -27.75% |
| Sep 30, 2018 | -49.74% |
| Jun 30, 2018 | 42.88% |
| Mar 31, 2018 | 89.48% |